Skip to main content
SpringerLink
Log in

In vitro and in vivo characterisation of nor-β-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Radiolabelled 2β-Cabomethoxy-3β-(4-iodophenyl)tropane (β-CIT) has been used in clinical studies for the imaging of dopamine and serotonin transporters with single-photon emission tomography (SPET). 2β-Carbomethoxy-3β-(4-iodophenyl)nortropane (nor-β-CIT) is a des-methyl analogue of β-CIT, which in vitro has tenfold higher affinity (IC50=0.36 nM) to the serotonin transporter than β-CIT (IC50=4.2 nM). Nor-β-CIT may thus be a useful radioligand for imaging of the serotonin transporter. In the present study iodine-125 and carbon-11 labelled nor-β-CIT were prepared for in vitro autoradiographic studies on post-mortem human brain cryosections and for in vivo positron emission tomography (PET) studies in Cynomolgus monkeys. Whole hemisphere autoradiography with [125I]nor-β-CIT demonstrated high binding in the striatum, the thalamus and cortical regions of the human brain. Addition of a high concentration (1 μM) of citalopram inhibited binding in the thalamus and the neocortex, but not in the striatum. In PET studies with [11C]nor-β-CIT there was rapid uptake of radioactivity in the monkey brain (6% of injected dose at 15 min) and high accumulation of radioactivity in the striatum, thalamus and neocortex. Thalamus to cerebellum and cortex to cerebellum ratios were 2.5 and 1.8 at 60 min, respectively. The ratios obtained with [11C]nor-β-CIT were 20%–40% higher than those previously obtained with [11C]β-CIT. Radioactivity in the thalamus and the neocortex but not in the striatum was displaceable with citalopram (5 mg/kg). In conclusion, nor-β-CIT binds to the serotonin transporter in the primate brain in vitro and in vivo and has potential for PET and SPET imaging of the serotonin transporter in human brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors.J Clin Psychiatry 1990; 51: 9–12.

    Google Scholar 

  2. Cash R, Raisman R, Ploska A, Agid Y. High and low affinity3H-imipramine binding sites in control and Parkinsonian brain.Eur J Pharmacol 1985; 117: 71–80.

    Google Scholar 

  3. Palmer AM, Francis PT, Benton JS, et al. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.J Neurochem 1987; 48: 8–15.

    Google Scholar 

  4. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, DeSouza EB. MDMA effects in the brain: pharmacological profile and evidence of neurotoxicity from neurochemical and autoradiographic studies.J Pharmacol Exp Ther 1987; 241: 911–916.

    Google Scholar 

  5. Ricaurte GA, Molliver ME, Martello MB, Katz JL, Wilson MA, Martello AL. Dexfenfluramine neurotoxicity in brains of non-human primates.Lancet 1990; 338: 1487–1488.

    Google Scholar 

  6. Neumeyer JL, Wang S, Milius RA, et al. [123I]2β-carbome-thoxy-3β-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.J Med Chem 1991; 34: 3144–3146.

    Google Scholar 

  7. Kuikka JT, Bergström KA, Vanninen E, Laulumaa V, Hartikainen P, Länsimies E. Initial experience with SPET examinations using [123I]2β-carbomethoxy-3β-(4-iodophenyl)tropane ([123I]β-CIT) in human brain.Eur J Nucl Med 1993; 20: 783–786.

    Google Scholar 

  8. Brücke T, Kornhuber J, Angelberger P, Asenbaum S, Frassine H, Podreka I. SPECT imaging of dopamine and serotonin transporters with [123I]β-CIT. Binding kinetics in the human brain.J Neural Transm Gen Sect 1993; 94: 137–146.

    Google Scholar 

  9. Innis RB, Seibyl JB, Wallace E et al. SPECT imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease.Proc Natl Acad Sci USA 1993; 90: 11965–11969.

    Google Scholar 

  10. Müller L, Halldin C, Farde L, et al. [11C]β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations.Nucl Med Biol 1993; 20: 249–255.

    Google Scholar 

  11. Farde L, Halldin C, Müller L, Suhari T Karlsson P, Hall H. PET study of [11C]β-CIT binding to monoamine transporters in the monkey and human brain.Synapse 1994; 16: 93–103.

    Google Scholar 

  12. Bergström KA, Kuikka JT, Ahonen A, Vanninen E. [123I]β-CIT, a tracer for dopamine reuptake sites, preparation and preliminary SPET studies in humans.J Nucl Biol Med 1994; 38 Suppl 1-4: 128–131.

    Google Scholar 

  13. Tiihonen J, Kuikka J, Bergström K, et al. Altered striatal dopamine re-uptake site densities in habitually violent and nonviolent alcoholics.Nature Med 1995; 1: 654–657.

    Google Scholar 

  14. Kuikka JT, Tiihonen J, Bergström KA, et al. Imaging of serotonin and dopamine transporters in the living human brain.Eur J Nucl Med 1995; 22: 346–350.

    Google Scholar 

  15. Bäekström I, Bergström M, Marcusson J. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.Brain Res 1989; 486: 261–268.

    Google Scholar 

  16. Arranz B, Marcusson J. [3H]Paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study.J Neural Transm Gen Sect 1994; 97: 27–40.

    Google Scholar 

  17. Boja JW, Kuhar MJ, Kopajtic T, et al. Secondary amine analogues of 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid esters andN-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters.J Med Chem 1994; 37: 1220–1223.

    Google Scholar 

  18. Dorman GA, Kaczmarczyk SJ, Paxinos G, et al. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H]mazindol autoradiography.J Comp Neurol 1991; 304: 419–434.

    Google Scholar 

  19. Bäckström IT, Marcusson JO. High- and low-affinity [3H]desipramine-binding sites in human postmortem brain tissue.Neuropsychobiology 1990; 23: 68–73.

    Google Scholar 

  20. Swahn C-G, Halldin C, Günther I, Patt J, Ametamey S. Synthesis of unlabelled,3H- and125I-labelled β-CIT and its ω-fluoroalkyl analogues β-CITFE and β-CIT FP including the synthesis of precursors.J Label Cmpds Radiopharm 1996; 38: 675–685.

    Google Scholar 

  21. Lundkvist C, Halldin C, Swahn C-G, et al. Synthesis of11Cor18F-labelled analogues of β-CIT. Labelling in different positions and PET evaluation in Cynomolgus monkeys.J Label Cmpds Radiopharm 1995; 37: 52–54.

    Google Scholar 

  22. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.Neuropsychopharmacology 1994; 11: 245–256.

    Google Scholar 

  23. Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride.Synapse 1996; 23: 115–123.

    Google Scholar 

  24. Persson A, d'Argy R, Gillberg P-G, et al. Autoradiography with saturation experiments of11C-Ro 15-1788 binding to human brain sections.J Neurosci Methods 1991; 36: 53–61.

    Google Scholar 

  25. Hyttel J. Citalopram: pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 277–295.

    Google Scholar 

  26. Andersen PH. The dopamine uptake inhibitor GBR12909: selectivity and molecular mechanisms of action.Eur J Pharmacol 1989; 166: 493–504.

    Google Scholar 

  27. Weinhard K, Dahlbom M, Eriksson L, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner.J Comput Assist Tomogr 1994; 18: 110–118.

    Google Scholar 

  28. Karlsson P, Farde L, Halldin C, et al. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.Psychopharmacology 1993; 113: 149–156.

    Google Scholar 

  29. Halldin C, Swahn C-G, Farde L, Sedvall G. Radioligand disposition and metabolism — key information in early drug development. In: Comar D, ed.PET for drug development and evaluation. Dordrecht: Kluwer; 1995: 55–65.

    Google Scholar 

  30. Bergström KA, Halldin C, Kuikka JT, et al. Lipophilic metabolite of [123I]β-CIT in human plasma may obstruct quantitation of the dopamine transporter.Synapse 1995; 19: 297–300.

    Google Scholar 

  31. Bergström KA, Halldin C, Lundkvist C, et al. Characterization of C-11 or I-123 labelled β-CIT-FP and β-CIT FE metabolism in monkey and human plasma. Identification of two labelled metabolites with HPLC.Hum Psychopharmacol 1996; 11: 483–490.

    Google Scholar 

  32. Swahn C-G, Halldin C, Farde L, Sedvall G. Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC.Hum Psychopharmacol 1994; 9: 25–31.

    Google Scholar 

  33. Marcusson J, Eriksson K. [3H]GBR-12935 binding to dopamine uptake sites in the human brain.Brain Res 1988; 457: 122–129.

    Google Scholar 

  34. Günther I, Hall H, Halldin C, Swahn C-G, Farde L, Sedvall G. Autoradiographic evaluation of [125I]β-CIT, [125I]β-CIT-FE and [125I]β-CIT FP binding in the human brain.Nucl Med Biol (in press)

  35. Gatley SJ, Volkow ND, Fowler JS, Dewey SL, Logan J. Sensitivity of striatal [11C]cocaine binding to decreases in synaptic dopamine.Synapse 1995; 20: 137–144.

    Google Scholar 

  36. Dray A, Davies J, Oakley N, Tongroach P, Vellucci S. The dorsal and medial raphe projrections to the substantia nigra in the rat: electrophysical, biochemical and behavioral observations.Brain Res 1978: 151: 431–442.

    Google Scholar 

  37. Spampinato U, Esposito E, Samanin R. Serotonergic agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigrostriatal neurons is intact.J Neurochem 1985; 980–982.

  38. Ugedo L, Grenhoff G, Svensson TH. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.Psychopharmacology 1989; 98: 45–50.

    Google Scholar 

  39. Dewey SL, Smith GS, Logan J, et a1. Serotonergic modulation of striatal dopamine measured with positron emission tomography and in vivo microdialysis.J Neurosci 1995; 15: 821–829.

    Google Scholar 

  40. Suehiro M, Scheffel U, Dannals RF, Ravert HT. Ricaurte GA, Wagner HN Jr. A PET radiotracer for studying serotonin uptake sites: carbon-ll-McN-56522.J Nucl Med 1993; 34: 120–127.

    Google Scholar 

  41. Mazière B, Mazière M. Studying in vivo brain chemistry with SPECT: receptors and neurotransmission. In: Costa DC, Morgan GF, Lassen NA. eds.New trends in nculear neurology and psychiatry. London: John Libbey; 1993: 85–100.

    Google Scholar 

  42. Jagust WJ, Eberling JL, Roberts JA, et al. In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I[5-iodo-6-nitroquipazin.Eur J Pharmacol 1993; 242: 189–193.

    Google Scholar 

  43. Szabo Z, Kao PF, Scheffel U. et al. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652.Synapse 1995; 20: 37–43.

    Google Scholar 

  44. Jagust WJ, Eberlin JL, Biegon A, et al. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter.J Nucl Med 1996; 37: 1207–1214.

    Google Scholar 

  45. Misra AL, Pontani RB, Vadlamani NL. Metabolism of norcocaine,N-hydroxy norcocaine and cocaine-N-oxide in the rat.Xenobiotica 1979; 9: 189–199.

    Google Scholar 

  46. Jindal SP, Lutz T. Ion cluster techniques in drug metabolism: use of a mixture of labeled and unlabeled cocaine to facilitate metabolite identification.J Anal Toxicol 1986; 10: 150–155.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-17176, Stockholm, Sweden

    Kim A. Bergström, Christer Halldin, Håkan Hall, Camilla Lundkvist, Nathalie Ginovart, Carl-Gunnar Swahn & Lars Farde

  2. Department of Clinical Physiology, Kuopio University Hospital, FIN-70210, Kuopio, Finland

    Kim A. Bergström

Authors
  1. Kim A. Bergström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christer Halldin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Håkan Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Camilla Lundkvist
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nathalie Ginovart
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carl-Gunnar Swahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lars Farde
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergström, K.A., Halldin, C., Hall, H. et al. In vitro and in vivo characterisation of nor-β-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain. Eur J Nucl Med 24, 596–601 (1997). https://doi.org/10.1007/BF00841395

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00841395

Key words

Search

Navigation